C0033306||Progestin
C1516362||cell viability
C1456820||tumor necrosis factor-α
C0014175||endometriotic
C0162597||stromal cells
C0014175||Endometriosis
C0014939||estrogen
C1290884||inflammatory disease
C0033306||Progestins
C1708063||first-line treatment
C0014175||endometriosis
C0034833||pituitary progesterone receptors
C1535931||suppression of systemic estrogen
C0087111||optimal treatment
C0033306||progestins
C0014175||endometriotic
C0597032||cells
C0014180||Endometrial
C0162597||stromal cells
C0162597||Endometrial stromal cells
C0043210||women
C0014175||endometriosis
C1456820||TNF-α
C0014406||environment
C0162597||Endometrial stromal cells
C0033306||progestins
C0065864||medroxyprogesterone acetate
C0065864||medroxyprogesterone acetate
C0068980||norethisterone acetate
C0068980||norethisterone acetate
C0057916||dienogest
C0057916||dienogest
C0079189||cytokine
C1158816||mRNA production
C1159339||protein secretion
C2986858||cell viability measured
C0057916||dienogest
C0068980||norethisterone acetate
C0065864||medroxyprogesterone acetate
C3155041||secretion of interleukin
C0021760||(IL)-6
C0079633||IL-8
C0128897||monocyte chemotactic protein (MCP)-1
C0162597||Endometrial stromal cells
C0057916||dienogest
C0068980||norethisterone acetate
C1456820||TNF-α
C1158816||mRNA production
C0033306||progestins
C1456820||TNF-α
C0596290||ESC proliferation
C0033306||Progestins
C0014175||endometriotic
C0162597||stromal cells
C0243095||altering the inflammatory microenvironment